Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Amortization of Deferred Charges (2023 - 2025)

Sanara MedTech (SMTI) has disclosed Amortization of Deferred Charges for 6 consecutive years, with $598172.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Amortization of Deferred Charges rose 128.14% year-over-year to $598172.0, compared with a TTM value of $2.0 million through Sep 2025, up 370.17%, and an annual FY2024 reading of $838965.0, up 16228.63% over the prior year.
  • Amortization of Deferred Charges was $598172.0 for Q3 2025 at Sanara MedTech, up from $583920.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $598172.0 in Q3 2025 and bottomed at $3083.0 in Q4 2023.
  • Average Amortization of Deferred Charges over 3 years is $304433.0, with a median of $336758.0 recorded in 2024.
  • The sharpest move saw Amortization of Deferred Charges soared 13357.61% in 2024, then surged 128.14% in 2025.
  • Year by year, Amortization of Deferred Charges stood at $3083.0 in 2023, then skyrocketed by 13357.61% to $414898.0 in 2024, then skyrocketed by 44.17% to $598172.0 in 2025.
  • Business Quant data shows Amortization of Deferred Charges for SMTI at $598172.0 in Q3 2025, $583920.0 in Q2 2025, and $411324.0 in Q1 2025.